BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32394774)

  • 1. Identification of gene expression markers and development of evaluation method using cell-based and RT-PCR-based assay for skin sensitising potential of chemicals.
    Nishikawa MU; Iwaki M; Tashiro K; Kurose K
    Xenobiotica; 2020 Nov; 50(11):1359-1369. PubMed ID: 32394774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
    Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
    Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the predictive nature of the Genomic Allergen Rapid Detection (GARD) assay with mammalian assays in determining the skin sensitisation potential of agrochemical active ingredients.
    Masinja W; Elliott C; Modi S; Enoch SJ; Cronin MTD; McInnes EF; Currie RA
    Toxicol In Vitro; 2021 Feb; 70():105017. PubMed ID: 33038465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA).
    Ashikaga T; Sakaguchi H; Sono S; Kosaka N; Ishikawa M; Nukada Y; Miyazawa M; Ito Y; Nishiyama N; Itagaki H
    Altern Lab Anim; 2010 Aug; 38(4):275-84. PubMed ID: 20822320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an
    Tanabe I; Yoshida K; Ishikawa S; Ishimori K; Hashizume T; Yoshimoto T; Ashikaga T
    Altern Lab Anim; 2023 Nov; 51(6):387-400. PubMed ID: 37796587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT.
    Sakaguchi H; Ashikaga T; Miyazawa M; Yoshida Y; Ito Y; Yoneyama K; Hirota M; Itagaki H; Toyoda H; Suzuki H
    Toxicol In Vitro; 2006 Aug; 20(5):774-84. PubMed ID: 16337770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 activation as a key event triggered by skin sensitisers: The development of the stable KeratinoSens reporter gene assay.
    Natsch A; Emter R
    Altern Lab Anim; 2016 Oct; 44(5):443-451. PubMed ID: 27805827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of chemicals as sensitisers based on new test methods.
    Botham PA
    Toxicol Lett; 1992 Dec; 64-65 Spec No():165-71. PubMed ID: 1471170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation.
    Basketter D; Poole A; Kimber I
    Regul Toxicol Pharmacol; 2017 Jun; 86():101-106. PubMed ID: 28274809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment.
    Maxwell G; Aeby P; Ashikaga T; Bessou-Touya S; Diembeck W; Gerberick F; Kern P; Marrec-Fairley M; Ovigne JM; Sakaguchi H; Schroeder K; Tailhardat M; Teissier S; Winkler P
    ALTEX; 2011; 28(1):50-5. PubMed ID: 21311850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new cell line based coculture system for skin sensitisation testing in one single assay using T cells, aryl hydrocarbon receptor knockout, and co-inhibitory blockage.
    Sonnenburg A; Stahlmann R; Kreutz R; Peiser M
    Arch Toxicol; 2023 Jun; 97(6):1677-1689. PubMed ID: 37147507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consideration of criteria required for assignment of a (skin) sensitiser a substance of very high concern (SVHC) under the REACH regulation.
    Basketter D; Kimber I
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):524-8. PubMed ID: 24893346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of skin sensitisation potential.
    Roberts DW; Aptula AO
    J Appl Toxicol; 2008 Apr; 28(3):377-87. PubMed ID: 17703504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes.
    Arkusz J; Stępnik M; Sobala W; Dastych J
    Toxicol Lett; 2010 Nov; 199(1):51-9. PubMed ID: 20713136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles for identification of High Potency Category Chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be applied.
    Roberts DW; Api AM; Safford RJ; Lalko JF
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):683-93. PubMed ID: 25765509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials.
    Sakaguchi H; Ryan C; Ovigne JM; Schroeder KR; Ashikaga T
    Toxicol In Vitro; 2010 Sep; 24(6):1810-20. PubMed ID: 20510347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test--human cell line activation test (h-CLAT).
    Sakaguchi H; Ashikaga T; Miyazawa M; Kosaka N; Ito Y; Yoneyama K; Sono S; Itagaki H; Toyoda H; Suzuki H
    Cell Biol Toxicol; 2009 Apr; 25(2):109-26. PubMed ID: 18204907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitability of macrophage inflammatory protein-1beta production by THP-1 cells in differentiating skin sensitizers from irritant chemicals.
    Lim YM; Moon SJ; An SS; Lee SJ; Kim SY; Chang IS; Park KL; Kim HA; Heo Y
    Contact Dermatitis; 2008 Apr; 58(4):193-8. PubMed ID: 18353026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The performance of an in vitro skin sensitisation test, IL-8 Luc assay (OECD442E), and the integrated approach with direct peptide reactive assay (DPRA).
    Kimura Y; Watanabe M; Suzuki N; Iwaki T; Yamakage K; Saito K; Nakajima Y; Fujimura C; Ohmiya Y; Omori T; Kojima H; Aiba S
    J Toxicol Sci; 2018; 43(12):741-749. PubMed ID: 30518712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A future approach to measuring relative skin sensitising potency: a proposal.
    Jowsey IR; Basketter DA; Westmoreland C; Kimber I
    J Appl Toxicol; 2006; 26(4):341-50. PubMed ID: 16773645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.